NCT06847828 is a NA clinical trial of QPL in Question Prompt List, sponsored by Den,Yu-Yun.

Who is sponsoring NCT06847828?

NCT06847828 is sponsored by Den,Yu-Yun.

What drugs are being tested in NCT06847828?

Interventions in NCT06847828: QPL.

What condition does NCT06847828 study?

NCT06847828 studies Question Prompt List, Caregivers, End-of-life Care.

Is NCT06847828 still recruiting?

NCT06847828 is currently completed. Last updated 26 February 2025.

Last reviewed 2025-02-26 · How we verify

NCT06847828

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effectiveness of Using a Palliative Care QPL on the Selfefficacy and Preparedness of Indonesian Homecare Workers

Completed NA Last updated 26 February 2025

What this trial tests

NA trial testing QPL in Question Prompt List in 60 participants. Completed in 31 December 2024.

Timeline

31 August 2023

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	Den,Yu-Yun
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	60
Start date	31 August 2023
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	1 location across Taiwan

Drugs / interventions tested

Conditions studied

Question Prompt List — all drugs for Question Prompt List →
Caregivers — all drugs for Caregivers →
End-of-life Care — all drugs for End-of-life Care →

Sponsor

Den,Yu-Yun

Who can join

Adults 20 to 65, female only, with Question Prompt List or Caregivers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Foreign studies on caregivers' use of QPL in end-of-life care, decision-making, and satisfaction are mostly conducted with family members who share the same language. Foreign family caregivers are a local cultural feature of Taiwan. This study explores the role of foreign family caregivers in end-of-life care in Taiwan. Cultural issues and differences, whether the number of questions asked, care readiness and self-efficacy can be increased after the intervention of the end-of-life care QPL, and the use of QPL that is appropriate for Indonesian culture to communicate and prepare for end-of-life care in hospice home care, is expected to provide A reference for communication between medical teams and foreign home caregivers and improvement of care quality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06847828 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Den,Yu-Yun
Last refreshed: 26 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06847828.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing